Jan. 07, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to ...

Supraliminal emotional faces also activated the right superior temporal sulcus (STS), the right posterior cingulate cortex, the right superior colliculi, the right inferior frontal gyrus (IFG) ...

This 1D color coding confirmed the dominant rostral-caudal axis among ZI voxels and their corresponding differences in connectivity from anterior prefrontal cortex to primary sensorimotor cortices ...

Repetitive transcranial magnetic stimulation (rTMS) and intermittent theta burst stimulation (iTBS) have been proven effective non-invasive treatments for patients with drug-resistant major depressive ...

Shares of CING stock opened at $4.81 on Friday. Cingulate has a twelve month low of $1.80 and a twelve month high of $88.44. The stock has a 50 day moving average of $4.36 and a 200 day moving ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Ready to start planning your care? Call us at 800-525-2225 to make an appointment.